Interventions to reduce weight gain in schizophrenia.

Area of Science:

• Psychiatry
• Clinical Psychology
• Pharmacology

Background:

• Weight gain is a significant concern for individuals with schizophrenia, impacting overall health.
• Effective strategies are needed to manage or prevent this common side effect.

Purpose of the Study:

• To evaluate the efficacy of pharmacological and non-pharmacological interventions for weight gain in schizophrenia patients.
• To identify effective strategies for reducing or preventing weight gain.

Main Methods:

• Systematic review of randomized controlled trials (RCTs) comparing interventions with standard care.
• Included pharmacological adjuncts and non-pharmacological approaches like diet and exercise counseling.
• Analyzed data using weighted mean differences (WMD) for weight change.

Main Results:

• Cognitive behavioral interventions showed significant weight loss (WMD -1.69 kg) in 3 RCTs.
• Pharmacological adjuncts modestly prevented weight gain (WMD -1.16 kg) across 6 RCTs.
• Cognitive behavioral interventions also showed significant effects in preventing weight gain (WMD -3.38 kg) in 2 RCTs.

Conclusions:

• Selective pharmacological and non-pharmacological interventions can achieve modest weight loss.
• Interpretation is limited by small study numbers, sample sizes, and intervention variability.
• More robust, longer-term studies are required to confirm efficacy and safety; current evidence doesn't support general pharmacological use for weight management in schizophrenia.